drugset / Trial / NCT00392041
Eszopiclone in the Treatment of Insomnia and Fibromyalgia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose is to assess the efficacy of eszopiclone for the treatment of insomnia and other symptoms of fibromyalgia. It is hypothesized that participants receiving eszopiclone will report greater improvement in total sleep time, sleep quality, pain, fatigue, physical functioning, and emotional distress than will those receiving placebo.
Timeline
- Start
- 2006-08
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 3 mg | — |